What happened
ViGenCell reported separate results for FY2025: revenue of US$15.7K (−92% year on year), an operating loss of US$11.8M and a net loss of US$11.3M.
Korean rules require this filing when revenue or profit moves 30% or more from the prior year (15% for large companies). The figures are the company's own and may not be audited yet.
| Revenue | US$15.7K |
|---|---|
| Revenue vs a year earlier | −92% |
| Operating profit | −US$11.8M |
| Net income | −US$11.3M |
| Period | FY2025 (separate) |
| Filed | 2026-02-04, Change of 30% or more in revenue or profit/loss structure (15% for large companies) |
| Source | DART rcept 20260204900749 → open original filing |
Source: DART. Information only, not investment advice.